Posted on January 24, 2008 by Debra A. McCurdy

FDA Biologics Facilities Site Visits

The FDA Center for Biologics Evaluation and Research (CBER) is inviting biologics facilities to participate in its Regulatory Site Visit Training Program, which is intended to allow CBER staff to directly observe routine biologics manufacturing practices. Interested parties should contact CBER by February 21. For details, click here. 

Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/71597
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.